Tendinitis Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, China, Germany, UK, Japan, India, France, Italy, South Korea - Size and Forecast 2024-2028

Tendinitis Treatment Market Size 2024-2028 

The tendinitis treatment market size is forecast to increase by USD 4.73 billion at a CAGR of 6.2% between 2023 and 2028.

• The increasing prevalence of musculoskeletal conditions, such as Tennis elbow and Pitcher's elbow, Jumper's knee, and other tendon-related injuries, is driving market demand. Additionally, the aging population is a contributing factor, as older adults are more susceptible to these conditions. Furthermore, the high cost of treatment, including surgical procedures and specialized care in hospitals, specialty clinics, home care settings, retail pharmacies, and online pharmacies, is also fueling market growth. Compression sleeves and ankle braces are popular non-surgical treatment options, and their availability in various channels is expanding market reach. Overall, the market is expected to continue growing due to these factors and the increasing awareness and focus on managing these conditions effectively.

What will the size of the market be during the forecast period?

 Request Free Sample

• The market encompasses various solutions aimed at alleviating the symptoms of tendinitis, an inflammatory condition affecting the tendons, often due to overuse or repetitive motion. Tendinitis can manifest in several forms, including Achilles tendinitis, supraspinatus tendinitis, tennis elbow, golfer's elbow, stenosing tenosynovitis, and trigger finger. Tendinitis can cause significant pain, swelling, and discomfort, leading to increased healthcare expenditure. Knee braces and other supportive devices may be recommended to help manage symptoms and prevent further damage. For cardiovascular patients and the elderly population, tendinitis can pose additional challenges due to underlying health conditions. Diagnosis of tendinitis typically involves a physical examination, with imaging tests such as ultrasound or MRI used to confirm the diagnosis. Treatment options range from over-the-counter pain relievers and physiotherapy to surgical procedures for severe cases. Orthopedic procedures and medical device manufacturers play a crucial role in the market, offering innovative solutions to help manage symptoms and improve patient outcomes. Sports activities and athletic injuries are common causes of tendinitis, making it a significant concern for the healthcare industry. Soft tissue injuries, including tendinitis, are on the rise due to increased participation in sports and physical activities. Healthcare advancements continue to emerge, with a focus on minimally invasive surgical procedures and targeted medication to address the underlying causes of tendinitis.

• The market is expected to grow due to the aging population and the increasing prevalence of sedentary lifestyles, leading to an increase in tendon injuries. The market is poised for growth, with a focus on developing effective, non-surgical treatment options and improving diagnostic tools to enable earlier intervention and better patient outcomes. In conclusion, the tendinitis treatment market is a critical area of focus for the healthcare industry, with a growing need for effective, non-invasive solutions to address the symptoms of tendinitis and prevent further damage. With a focus on healthcare advancements and innovative treatment options, the market is expected to continue growing, providing relief to those suffering from tendinitis and enabling them to maintain an active, pain-free lifestyle.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • Non-surgical treatment
  • Surgical treatment
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

By Type Insights

• The non-surgical treatment segment is estimated to witness significant growth during the forecast period.

Tendinitis, an inflammation of the tendons, often results from athletic injuries or overuse. Non-surgical treatment options include over-the-counter pain relievers, such as nonsteroidal anti-inflammatory drugs (NSAIDs), and steroid injections. NSAIDs function by obstructing the production of prostaglandins, which are responsible for inflammation and pain. These drugs primarily act in the affected area to inhibit prostaglandin synthesis. NSAIDs are categorized into COX-1 and COX-2 inhibitors. Although corticosteroid injections have been used to manage tendinitis symptoms, they are not typically the first-line treatment.

Furthermore, the choice of corticosteroid and dosage regimen varies based on the physician's clinical expertise and the patient's tolerance level. Specialty clinics, home healthcare, hospital pharmacies, retail pharmacies, and online pharmacies offer various tendinitis treatment alternatives. Patient epidemiology and demographics influence the demand for tendinitis treatment in the market.

Get a glance at the market report of share of various segments Request Free Sample

The non-surgical treatment segment was valued at USD 7.82 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 41% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The North American market is experiencing significant growth due to the rising prevalence of this condition, particularly among older adults and active individuals. Key factors fueling market expansion include an increase in sports-related injuries and heightened awareness of various treatment methods, such as physical therapy, which is frequently the initial intervention. However, obstacles like insufficient public knowledge regarding tendinitis and disparities in healthcare access may hinder market progress. Current tendencies indicate a transition towards non-surgical treatments, including physical therapy and shockwave therapy, as patients increasingly opt for these alternatives. Furthermore, the integration of telehealth services is expanding the reach of specialized care, thereby bolstering market growth. The market in North America is poised for continued expansion as innovative solutions emerge to address the evolving needs of patients.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Tendinitis Treatment Market?

The rising geriatric population is the key driver of the market.

• The prevalence of tendinitis, a condition characterized by inflammation and discomfort in the tendons, is on the rise, particularly among the elderly population. With aging comes an increased susceptibility to musculoskeletal issues due to the wear and tear on tendons over time. This demographic trend has resulted in a higher incidence of tendon-related conditions, leading to a growing demand for effective treatment options. Older adults often experience swelling and pain in their tendons, which can be worsened by reduced physical activity and muscle imbalances. As the elderly population continues to prioritize active lifestyles, there is a significant need for innovative medical solutions to address their unique requirements.

• The healthcare expenditure on tendinitis treatment is expected to increase in response to this trend. Knee braces and other supportive devices are commonly used to alleviate the pain and discomfort associated with tendinitis, particularly in the knee area. Cardiovascular health is also a crucial factor in managing tendinitis, as poor cardiovascular health can exacerbate inflammation and slow down the healing process. Therefore, a holistic approach to treatment, incorporating both medical interventions and lifestyle modifications, is essential for effective tendinitis management. Thus, such factors are driving the growth of the market during the forecast period.

What are the market trends shaping the Tendinitis Treatment Market?

Increasing healthcare expenditure is the upcoming trend in the market.

• The market is experiencing growth due to escalating healthcare expenditures in various regions, particularly in North America. With increased investments in healthcare systems, innovative therapies such as physical therapy, shockwave therapy, and platelet-rich plasma (PRP) therapy are becoming more accessible. Preventive care and early intervention are also priorities for healthcare providers, as they aim to prevent musculoskeletal disorders like tendinitis from progressing into more serious complications.

• Furthermore, rising disposable incomes enable patients to afford higher-quality treatment options. Tendinitis, including conditions like Tennis elbow and Pitcher's elbow, as well as Jumper's knee, are common tendon-related injuries. Treatment methods vary, from home care settings with the use of ankle braces and compression sleeves to specialty clinics and surgical interventions. Both retail pharmacies and online pharmacies offer a range of medications and therapies to help manage the symptoms of tendinitis. Thus, such trends will shape the growth of the market during the forecast period.

What challenges does Tendinitis Treatment Market face during its growth?

The high cost of treatment of tendinitis is a key challenge affecting the market growth.

• Tendinitis, an inflammation of the tendons, can result in a substantial financial burden due to its treatment costs. These costs can pose a significant financial strain on patients, especially those without comprehensive insurance coverage or high out-of-pocket expenses due to insurance deductibles. The economic impact of tendinitis extends beyond individual patients to employers and the healthcare system.

• Employers face direct costs related to tendinitis cases, which can range from USD 2,000 to USD 4,000 per employee. Indirect costs, such as lost productivity and absenteeism, further compound the economic burden. In the US, the total economic impact of tendinitis exceeds USD 22 billion annually, considering both direct care costs and indirect losses due to reduced workforce efficiency. Advanced imaging technologies, including ultrasound and MRI, play a crucial role in diagnosing tendinitis. Treatment modalities include shockwave therapy, 3D printing, robot-assisted surgery, functional electrical stimulation, and medications. Physical therapy is also an essential component of tendinitis treatment. Hence, the above factors will impede the growth of the market during the forecast period

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Alvogen Inc
• AstraZeneca Plc
• Aurobindo Pharma Ltd.
• Bayer AG
• Divis Laboratories Ltd.
• Dobecure S.L.
• Dr Reddys Laboratories Ltd.
• GlaxoSmithKline Plc
• HydroCision Inc.
• Johari Digital India Ltd.
• Merck and Co. Inc.
• MetrioPharm AG
• MiMedx Group Inc.
• RAG Stiftung
• Seikagaku Corp.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Tendinitis, a condition characterized by inflammation, pain, swelling, and discomfort in the tendons, is a common health issue affecting individuals across various age groups and populations. The primary causes include overuse and repetitive motion, leading to tendon strain. Tendinitis can occur in different parts of the body, such as the elbow, shoulder, Achilles, and ankle. The elderly population and athletes are particularly susceptible to tendon-related injuries due to the natural aging process and sports activities. The market encompasses various options, ranging from medications and physical therapy to advanced imaging technologies and surgical procedures. Hospitals, specialty clinics, home healthcare settings, retail pharmacies, and online pharmacies are the primary channels for accessing these treatments. Musculoskeletal conditions, including tendinitis, are a significant contributor to healthcare expenditure.

Furthermore, advancements in healthcare, such as the use of ultrasound, MRI, shockwave therapy, 3D printing, robot-assisted surgery, functional electrical stimulation, and cold therapy, have revolutionized the diagnosis and treatment of tendinitis. Medications, physical therapy, and orthopedic procedures are common treatment options for tendonitis. Over-the-counter pain relievers and surgical procedures are used for managing symptoms and addressing severe cases, respectively. Geriatric diseases and sports-related injuries are significant drivers for the market.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch